Results 161 to 170 of about 3,156 (181)

Losartan ameliorates dystrophic epidermolysis bullosa and uncovers new disease mechanisms

EMBO Molecular Medicine, 2015
Alexander Nyström, Kerstin Thriene, Dimitra Kiritsi   +2 more
exaly  

Dystrophic Epidermolysis Bullosa

Archives of Dermatology, 1985
openaire   +1 more source

Mutation analysis and characterization of COL7A1 mutations in dystrophic epidermolysis bullosa

Experimental Dermatology, 2008

exaly  

Surgical management of hand deformities in patients with recessive dystrophic epidermolysis bullosa

Journal of Plastic Surgery and Hand Surgery, 2020
Xianyu Zhou, Jinny Huang, Jun Yang
exaly  

Recessive dystrophic epidermolysis bullosa. Evidence for increased collagenase as a genetic characteristic in cell culture.

Journal of Experimental Medicine, 1978
Eugene A Bauer, A Z Eisen
exaly  

Intradermal Injection of Lentiviral Vectors Corrects Regenerated Human Dystrophic Epidermolysis Bullosa Skin Tissue in Vivo

Molecular Therapy, 2004
David T Woodley, Douglas R Keene, Mei Chen   +2 more
exaly  

Dilated cardiomyopathy in dystrophic epidermolysis bullosa: a lethal complication of epidermolysis bullosa

European Journal of Anaesthesiology, 2002
P M D, Cunnington, R, Addison
openaire   +2 more sources

Analysis of the COL7A1 gene in Czech patients with dystrophic epidermolysis bullosa reveals novel and recurrent mutations

Journal of Dermatological Science, 2010
Karel Vesely, Lenka Fajkusova
exaly  

Patent landscape of molecular and cellular targeted therapies for recessive dystrophic epidermolysis bullosa

Expert Opinion on Therapeutic Patents, 2019
Mari Cleide Sogayar
exaly  

CRISPR/Cas9-based targeted genome editing for correction of recessive dystrophic epidermolysis bullosa using iPS cells

Proceedings of the National Academy of Sciences of the United States of America, 2019
Joanna Jackow, Zongyou Guo, Corey Hansen   +2 more
exaly